person
Iwona Ł.
- Country
- Poland
- Department
- Oddział Badań Wczesnych Faz
Research Overview
assignment
39
Clinical Trials ·
- Evaluation of Balstilimab Monotherapy in Advanced/Metastatic Non-Melanoma Skin Cancers: A Phase 2 Open-Label Study
- Bioavailability and Bioequivalence Assessment of Niraparib and Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients
- Phase 1 Study of CLN-619 Alone or with Pembrolizumab in Advanced Solid Tumors, Including NSCLC, Cervical, Endometrial, Ovarian, Breast, and Gastrointestinal Cancers
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
108
Sites with multiple studies
Has run more than one trial at 108 of 249 partner sites.
Specializations
Advanced Solid Tumors
The investigator specializes in treating various forms of advanced solid tumors, with particular emphasis on innovative therapeutic approaches and novel treatment combinations.
- HER2 Expressing Tumors
- Non-small Cell Lung Cancer
- Colorectal Cancer
- Gastric Cancer
Gynecologic Oncology
Focused on treating aggressive forms of gynecologic cancers, particularly high-grade serous ovarian cancer and related conditions affecting the reproductive system.
- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
- Hormone Receptor-Positive Breast Cancer
Specialized Cancer Types
The investigator has expertise in treating distinct cancer varieties, including non-melanoma skin cancers and various urological malignancies.
- Renal Cell Carcinoma
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Small Cell Lung Cancer
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.